{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:27:08Z","timestamp":1787009228195,"version":"build-2736575974"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Histoplasmosis presents a substantial clinical challenge globally, with a particular prevalence in South America, especially among patients with concurrent Human Immunodeficiency Virus (HIV) infection. Despite itraconazole's established efficacy, investigating alternative therapeutic approaches remains imperative. This is the largest study in our region to date, assessing the effectiveness of the less explored posaconazole treatment. This observational study, conducted at Fundaci\u00f3n Valle del Lili (FVL) from 2016 to 2022, encompassed adults with disseminated histoplasmosis. Patients (n\u00a0=\u00a031) were treated with liposomal amphotericin B as an initial treatment, followed by consolidation treatment with posaconazole or itraconazole. Patients with single-organ cases, those lacking microbiological diagnosis, those who received initial treatment with antifungals other than liposomal Amphotericin B and those with\u00a0&amp;lt;\u00a06 months follow-up were excluded (Figure 1). Analyses considered population characteristics, treatments, and outcomes. Patients (average age: 45.6; 58.1% female) had common comorbidities (HIV 38.7%, solid organ transplantation 29% and oncologic disease 12.9%). Lungs (48.4%) and lymph nodes (16.1%) were commonly affected. Biopsy (64.5%) was the primary diagnostic method. Initial treatment with liposomal amphotericin B (100%) was given for 14 days on average. Follow-up indicated 71% completion with 19.4% requiring treatment modifications. Notably, 70.9% completed a posaconazole consolidation regimen over 350 days on average. Drug interactions during consolidation (80.6%) were common. No relapses occurred, and three deaths unrelated to histoplasmosis were reported. Traditionally, itraconazole has been the prevalent initial treatment; however, in our cohort, 55.9% of patients received posaconazole as the primary option. Encouragingly, posaconazole showed favorable tolerance and infection resolution, suggesting its potential as an effective and well-tolerated alternative for consolidation treatment. This finding prompts further exploration of posaconazole, potentially leading to more effective patient care and better outcomes.<\/jats:p>","DOI":"10.1093\/mmy\/myae058","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:12:27Z","timestamp":1716829947000},"source":"Crossref","is-referenced-by-count":6,"title":["Management of disseminated histoplasmosis in a high-complexity clinic in Cali, Colombia"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-2685","authenticated-orcid":false,"given":"Natalia","family":"Ramos-Ospina","sequence":"first","affiliation":[{"name":"Clinical Research Center, Fundaci\u00f3n Valle del Lili , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5019-3213","authenticated-orcid":false,"given":"Indira","family":"Carolina\u00a0Lambertinez-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Universidad Icesi , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5954-4729","authenticated-orcid":false,"given":"Leidy","family":"Johanna\u00a0Hurtado-Berm\u00fadez","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Fundaci\u00f3n Valle del Lili , 760032 Cali , Colombia"},{"name":"Faculty of Health Sciences, Universidad Icesi , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-2844","authenticated-orcid":false,"given":"Jenny","family":"Patricia\u00a0Mu\u00f1oz-Lombo","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Universidad Icesi , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-0345","authenticated-orcid":false,"given":"Juan","family":"Diego\u00a0V\u00e9lez-Londo\u00f1o","sequence":"additional","affiliation":[{"name":"Service of Infectious Diseases, Department of Internal Medicine, Fundaci\u00f3n Valle del Lili , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0638-8099","authenticated-orcid":false,"given":"Jorge","family":"Andr\u00e9s\u00a0Valencia-Montagut","sequence":"additional","affiliation":[{"name":"Service of Infectious Diseases, Department of Internal Medicine, Fundaci\u00f3n Valle del Lili , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-3016","authenticated-orcid":false,"given":"Pablo","family":"Andr\u00e9s\u00a0Moncada-Vallejo","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Universidad Icesi , 760032 Cali , Colombia"},{"name":"Service of Infectious Diseases, Department of Internal Medicine, Fundaci\u00f3n Valle del Lili , 760032 Cali , Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"1","key":"2024070915013931700_bib1","doi-asserted-by":"crossref","first-page":"e2638","DOI":"10.1371\/journal.pntd.0002638","article-title":"Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana","volume":"8","author":"Nacher","year":"2014","journal-title":"PLoS NeglTrop Dis"},{"key":"2024070915013931700_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0123-9392(10)70127-2","article-title":"Histoplasmosis en pacientes con sida. Un estudio de cohorte en Medell\u00edn, Colombia","volume":"14","author":"Uribe","year":"2010","journal-title":"Infectio"},{"issue":"10","key":"2024070915013931700_bib3","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1473-3099(18)30354-2","article-title":"Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study","volume":"18","author":"Adenis","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2024070915013931700_bib4","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jinf.2005.01.001","article-title":"A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole","volume":"51","author":"Clark","year":"2005","journal-title":"J Infect"},{"issue":"4","key":"2024070915013931700_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jinf.2006.05.006","article-title":"Salvage treatment of histoplasmosis with posaconazole","volume":"54","author":"Restrepo","year":"2007","journal-title":"J Infect"},{"issue":"suppl_1","key":"2024070915013931700_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/ofid\/ofw172.1346","article-title":"Comparison of posaconazole and itraconazole for treatment of histoplasmosis","volume":"3","author":"Bobbili","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2024070915013931700_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tmaid.2017.03.010","article-title":"Infections associated with adventure travel: a systematic review","volume":"16","author":"Gundacker","year":"2017","journal-title":"Travel Med Infect Dis"},{"issue":"10","key":"2024070915013931700_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1473-3099(18)30373-6","article-title":"Histoplasmosis dethrones tuberculosis in Latin America","volume":"18","author":"Pasqualotto","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2024070915013931700_bib9","doi-asserted-by":"crossref","first-page":"e00220","DOI":"10.1002\/rcr2.220","article-title":"Disseminated histoplasmosis: a rare clinical phenotype with difficult diagnosis","volume":"5","author":"Xiong","year":"2017","journal-title":"Respirol Case Rep"},{"issue":"7","key":"2024070915013931700_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2024070915013931700_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/myc.12337","article-title":"Histoplasmosis and skin lesions in HIV : a safe and accurate diagnosis","volume":"58","author":"Moreno-Couti\u00f1o","year":"2015","journal-title":"Mycoses"},{"issue":"6","key":"2024070915013931700_bib12","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1053\/j.ajkd.2011.08.022","article-title":"Granulomatous interstitial nephritis associated with Ddisseminated histoplasmosis in an immunocompetent patient","volume":"58","author":"Qian","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2024070915013931700_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CVI.00389-10","article-title":"Histoplasma antigen clearance during treatment of histoplasmosis in patients with aids determined by a quantitative antigen enzyme immunoassay","volume":"18","author":"Hage","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"2024070915013931700_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jof5030080","article-title":"Getting histoplasmosis on the map of international recommendations for patients with advanced HIV disease","volume":"5","author":"Bongomin","year":"2019","journal-title":"J Fungi"},{"key":"2024070915013931700_bib15","volume-title":"Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV [Internet]","year":"2020"},{"issue":"2","key":"2024070915013931700_bib16","doi-asserted-by":"crossref","first-page":"ofu070","DOI":"10.1093\/ofid\/ofu070","article-title":"Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings","volume":"1","author":"Bahr","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"2024070915013931700_bib17","first-page":"CD013594","article-title":"Treating progressive disseminated histoplasmosis in people living with HIV","volume":"4","author":"Murray","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2024070915013931700_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/jof4040133","article-title":"Pre-existing liver disease and toxicity of antifungals","volume":"4","author":"Spernovasilis","year":"2018","journal-title":"J Fungi"},{"issue":"1","key":"2024070915013931700_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ejh.12886","article-title":"Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: a case report and review of the literature","volume":"99","author":"Schulze","year":"2017","journal-title":"Eur J Haematol"},{"issue":"4","key":"2024070915013931700_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14787210.3.4.467","article-title":"Posaconazole: clinical pharmacology and potential for management of fungal infections","volume":"3","author":"Groll","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"2024070915013931700_bib21","doi-asserted-by":"crossref","first-page":"e3727","DOI":"10.1093\/cid\/ciaa1555","article-title":"Voriconazole versus itraconazole for the initial and step-down treatment of histoplasmosis: a retrospective cohort","volume":"73","author":"Hendrix","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2024070915013931700_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mmcr.2019.12.013","article-title":"HIV-associated disseminated histoplasmosis successfully treated with isavuconazole consolidation therapy","volume":"27","author":"Mazzella","year":"2020","journal-title":"Med Mycol Case Rep"},{"issue":"5","key":"2024070915013931700_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejps.2004.01.005","article-title":"Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study","volume":"21","author":"Wexler","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"2024070915013931700_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myae058\/57955580\/myae058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/7\/myae058\/58483669\/myae058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/62\/7\/myae058\/58483669\/myae058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T12:16:46Z","timestamp":1720527406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myae058\/7684287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myae058","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,28]]},"article-number":"myae058"}}